Such patients include sick or premature neonates, neonates undergoing adoption or being transferred within or between hospitals, infants born at home, children of transient or homeless families, and infants born outside the United States and Canada. Document newborn screening results in an easily accessible part of the patient record for future reference. Follow-up Confirm all abnormal results with retesting. Prompt physical examination of patients with abnormal results is important. Start all patients with sickle cell disease on penicillin prophylaxis as soon as the diagnosis is confirmed.
Counseling Provide appropriate counseling to all parents of children with abnormal test results.
Provide information about the significance of the results and the need for retesting, the implications for the child's health, treatment regimens, symptoms to be alert for, and genetic issues for future childbearing. FDA Office of Consumer Affairs. Quick Reference Guide. An educational videotape depicting the LA4-A2 collection procedure is also available. Management and Therapy of Sickle Cell Disease.